A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Conditions: Neoplasms; Child; Adolescent Interventions: Drug: Ramucirumab; Drug: Cyclophosphamide; Drug: Vinorelbine; Drug: Gemcitabine; Drug: Docetaxel; Drug: Abemaciclib; Drug: Irinotecan; Drug: Temozolomide Sponsor: Eli Lilly and Company Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials